首页 | 本学科首页   官方微博 | 高级检索  
     


Concise and Practical Asymmetric Synthesis of a Challenging Atropisomeric HIV Integrase Inhibitor
Authors:Dr. Keith R. Fandrick  Dr. Wenjie Li  Dr. Yongda Zhang  Dr. Wenjun Tang  Joe Gao  Dr. Sonia Rodriguez  Nitinchandra D. Patel  Dr. Diana C. Reeves  Dr. Jiang‐Ping Wu  Sanjit Sanyal  Dr. Nina Gonnella  Dr. Bo Qu  Dr. Nizar Haddad  Dr. Jon C. Lorenz  Kanwar Sidhu  June Wang  Dr. Shengli Ma  Dr. Nelu Grinberg  Dr. Heewon Lee  Dr. Youla Tsantrizos  Dr. Marc‐André Poupart  Dr. Carl A. Busacca  Dr. Nathan K. Yee  Dr. Bruce Z. Lu  Dr. Chris H. Senanayake
Affiliation:1. Chemical Development, Boehringer‐Ingelheim Pharmaceuticals Inc. 900 Ridgebury Road, P.O. Box 368, Ridgefield, CT 06877‐0368 (USA);2. Research and Development, Boehringer Ingelheim (Canada) Ltd. 2100 Cunard Street, Laval, Québec H7S 2G5 (Canada)
Abstract:A practical and efficient synthesis of a complex chiral atropisomeric HIV integrase inhibitor has been accomplished. The combination of a copper‐catalyzed acylation along with the implementation of the BI‐DIME ligands for a ligand‐controlled Suzuki cross‐coupling and an unprecedented bis(trifluoromethane)sulfonamide‐catalyzed tert‐butylation renders the synthesis of this complex molecule robust, safe, and economical. Furthermore, the overall synthesis was conducted in an asymmetric and diastereoselective fashion with respect to the imbedded atropisomer.
Keywords:acylation  asymmetric synthesis  phosphine ligands  Suzuki couplings  tert‐butylation
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号